Sentinel 2.0 bridge contract

Active Definitive Contract Awarded Last action

Contract number
75F40126C00029
Awardee
Awarding agency
Obligated
$32,918,651

Award facts

Opportunity
Contract value 59% obligated
  • $32,918,651.06 Current, with exercised options
  • $55,804,505.06 Potential, with all options
Completion date 24% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Canton, MA 02021, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $22,435,157
Original award $10,483,494

About this award

The Food and Drug Administration awarded a $55.8 million definitive contract to Harvard Pilgrim Health Care, Inc. for Sentinel 2.0 bridge operations on March 29, 2026, under a sole-source justification. The contract runs through September 28, 2028.

This is a bridge contract awarded to the incumbent contractor to maintain continuity of the FDA's Sentinel System, a Congressionally mandated post-market medical product safety surveillance program established under the FDA Amendments Act of 2007. The solicitation, published as a special notice on January 28, 2026, describes services including program leadership, Active Risk Identification and Analysis System (ARIA) operations, real-world claims and electronic health records data integration, Atlassian access, and Federal Information Security Modernization Act compliance support. The Sentinel System currently serves data from at least 100 million individuals.

Performance is based in Canton, MA. The contract is firm fixed price with a six-month base period followed by two optional six-month periods. The sole-source justification rests on Harvard Pilgrim Health Care, Inc.'s incumbent status and demonstrated expertise in maintaining critical Sentinel System infrastructure, pending completion of a competitive Sentinel 3.0 procurement process.

Harvard Pilgrim Health Care, Inc.'s Office of Sponsored Programs Division is a non-profit health research organization with substantial prior federal health surveillance work, including operations of the FDA's ARIA system and CDC vaccine safety monitoring programs.

Quick answers

Who was awarded contract 75F40126C00029?

75F40126C00029 was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 29, 2026.

How much is contract 75F40126C00029 worth?

The government has obligated $32,918,651 on 75F40126C00029. Its potential value, with all options, is $55,804,505.

Was contract 75F40126C00029 competed?

The extent of competition for 75F40126C00029 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award